If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.544
Bid: 1.538
Ask: 1.544
Change: 0.032 (2.12%)
Spread: 0.006 (0.39%)
Open: 1.516
High: 1.55
Low: 1.49
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Separate Results

9 May 2018 07:00

RNS Number : 4262N
Commercial Intnl Bank (Egypt) SAE
09 May 2018
 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31st , 2018

 

 

FINANCIAL POSITION

As of March 31st, 2018

Amounts in EGP Thousands

Note

March 31st, 2018

December 31st , 2017

Assets

Cash and balances with central bank

15

26,182,232

14,663,289

Due from banks

16

42,306,844

45,319,766

Treasury bills and other governmental notes

17

45,937,458

54,478,202

Trading financial assets

18

7,170,208

7,295,197

Loans and advances to banks, net

19

188,312

1,313

Loans and advances to customers, net

20

95,115,591

88,427,103

Derivative financial instruments

21

38,274

40,001

Financial investments

- Available for sale

22

40,152,856

30,474,781

- Held to maturity

22

42,359,709

45,167,722

Investments in associates and subsidiaries

23

67,959

54,068

Other assets

24

8,293,920

6,886,807

Intangible assets

41

336,371

368,923

Deferred tax assets (Liabilities)

32

224,393

179,630

Property, plant and equipment

25

1,360,718

1,414,519

Total assets

309,734,845

294,771,321

Liabilities and equity

Liabilities

Due to banks

26

11,352,358

1,877,918

Due to customers

27

256,077,525

250,767,370

Derivative financial instruments

21

185,956

196,984

Current tax liabilities

896,492

2,778,973

Other liabilities

29

8,084,618

5,476,531

Other loans

28

3,687,828

3,674,736

Provisions

30

1,644,030

1,615,159

Total liabilities

281,928,807

266,387,671

Equity

Issued and paid up capital

31

11,618,011

11,618,011

Reserves

34

13,529,644

10,137,515

Reserve for employee stock ownership plan (ESOP)

596,636

489,334

Retained earnings*

2,076,436

6,138,790

Total equity

27,820,727

28,383,650

Total liabilities and equity

309,749,534

294,771,321

*Including net profit for the current period

INCOME STATEMENT

As of March 31st , 2018

Amounts in EGP Thousands

Note

March 31st , 2018

March 31st, 2017

Interest and similar income

7,936,316

6,376,570

Interest and similar expense

(4,676,400)

(3,593,103)

Net interest income

6

3,259,916

2,783,467

Fee and commission income

786,422

655,977

Fee and commission expense

(214,083)

(138,176)

Net fee and commission income

7

572,339

517,801

Dividend income

8

1,086

1,799

Net trading income

9

436,092

386,603

Profits (Losses) on financial investments

22

146,651

323,473

Administrative expenses

10

(957,074)

(746,457)

Other operating (expenses) income

11

(236,859)

(357,997)

Intangible assets amortization

41

(32,552)

(32,552)

Impairment charge for credit losses

12

(320,232)

(506,570)

Profit before income tax

2,869,367

2,369,567

Income tax expense

13

(896,492)

(598,735)

Deferred tax assets (Liabilities)

32 & 13

44,763

14,610

Net profit for the period

2,017,638

1,785,442

Earning per share

14

Basic

1.54

1.36

Diluted

1.51

1.34

 

CASH FLOW STATEMENT

As of March 31st , 2018

 

 

 

Amounts in EGP Thousands

 

March 31st , 2018

March 31st , 2017

Cash flow from operating activities

Profit before income tax

2,869,367

2,044,726

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

94,089

84,592

Impairment charge for credit losses

320,232

506,570

Other provisions charges

26,048

88,440

Available for sale investments exchange revaluation differences

39,053

16,596

Intangible assets amortization

32,552

32,552

Financial investments impairment charge

(16)

(59,574)

Exchange differences in financial investments in subsidiary

209

(358)

Utilization of other provisions

245

(2,470)

Other provisions no longer used

-

3,523

Exchange differences of other provisions

2,578

53,608

(Losses) Profits from selling financial investments

(146,635)

77,104

Shares based payments

107,302

(11,940)

Impairment (Released) charges of non current assets held for sale

-

2,833,369

Net decrease (increase) in assets and liabilities

Due from banks

(29,978,825)

(6,369,580)

Treasury bills and other governmental notes

8,624,987

(1,278,538)

Trading financial assets

124,989

235,913

Derivative financial instruments

(5,392)

6,832

Loans and advances to banks and customers

(7,195,719)

(1,095,248)

Other assets

(1,232,913)

(715,275)

Non current assets held for sale

-

188,136

Due to banks

9,474,440

(410,928)

Due to customers

5,354,264

7,765,546

Income tax obligations paid

(2,778,973)

(2,017,034)

Other liabilities

2,608,087

1,624,858

Net cash (used in) provided from operating activities

(11,660,031)

768,051

Cash flow from investing activities

Payment for purchases of subsidiary and associates

(10,575)

-

Payment for purchases of property, plant, equipment and branches constructions

(214,488)

(204,805)

Proceeds from redemption of held to maturity financial investments

2,808,013

7,111,107

Payment for purchases of held to maturity financial investments

-

(2,575,231)

Payment for purchases of available for sale financial investments

(10,484,844)

(153,395)

Proceeds from selling available for sale financial investments

303,449

480,343

Proceeds from selling non current assets held for sale

-

500,867

Net cash (used in) provided from investing activities

(7,598,445)

5,158,886

Cash flow from financing activities

Increase (decrease) in long term loans

13,092

(5,025)

Dividend paid

(2,143,177)

(773,274)

Net cash used in financing activities

(2,130,085)

(778,299)

Net increase (decrease) in cash and cash equivalent during the period

(21,388,561)

5,148,638

Beginning balance of cash and cash equivalent

49,208,837

61,518,700

Cash and cash equivalent at the end of the period

27,820,276

66,667,338

Cash and cash equivalent comprise:

Cash and balances with central bank

26,182,232

15,101,163

Due from banks

42,306,844

65,449,817

Treasury bills and other governmental notes

45,937,458

39,956,034

Obligatory reserve balance with CBE

(20,421,756)

(10,066,100)

Due from banks with maturities more than three months

(20,155,641)

(4,307,610)

Treasury bills with maturity more than three months

(46,028,861)

(39,465,966)

Total cash and cash equivalent

27,820,276

66,667,338

 

 

 

 

 

 

 

 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

 

Separate statement of changes in shareholders' equity for the period ended on March 31st, 2017

Mar. 31, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Capital reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

11,538,660

1,035,363

4,554,403

20,645

10,133

(2,180,244)

3,019

-

5,950,555

343,460

21,275,994

Transferred to reserves

-

297,444

4,300,607

-

1,682

-

-

-

(4,599,733)

-

-

Dividend paid

-

-

-

-

-

-

-

-

(1,350,207)

-

(1,350,207)

Net profit for the period

-

-

-

-

-

-

-

-

1,785,442

-

1,785,442

Net unrealised gain/(loss) on AFS

-

-

-

-

-

218,228

-

-

-

-

218,228

Transferred (from) to bank risk reserve

-

-

-

-

-

-

615

-

(615)

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

77,104

77,104

Balance at the end of the period

11,538,660

1,332,807

8,855,010

20,645

11,815

(1,962,016)

3,634

-

1,785,442

420,564

22,006,561

 

 

 

 

 

 

 

Separate statement of changes in shareholders' equity for the period ended on March 31st, 2018

 

 

 

Mar. 31, 2018

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Capital reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

11,618,011

1,332,807

9,000,023

20,645

11,815

(1,642,958)

3,634

1,411,549

6,138,790

489,334

28,383,650

Transferred to reserves

-

377,486

3,616,832

-

606

-

-

-

(3,994,924)

-

-

Dividend paid

-

-

-

-

-

-

-

-

(2,143,177)

-

(2,143,177)

Net profit for the period

-

-

-

-

-

-

-

-

2,017,638

-

2,017,638

Net unrealised gain/(loss) on AFS

-

-

-

-

-

(603,484)

-

-

-

-

(603,484)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

689

-

(689)

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

107,302

107,302

Balance at the end of the period

11,618,011

1,710,293

12,616,855

20,645

12,421

(2,246,442)

4,323

1,411,549

2,017,638

596,636

27,761,929

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/4262N_-2018-5-8.pdf 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFZMGGKNRKGRZM
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.